Medicine and Dentistry
COVID-19
95%
Severe Acute Respiratory Syndrome Coronavirus 2
85%
Patient
81%
Neutralizing Antibody
70%
Antibody
58%
Vaccine
53%
Assay
48%
Infection
46%
Antigen
45%
Diagnosis
36%
Blood Stasis
29%
Laboratory
28%
Antibody Response
25%
Thrombosis
24%
Humoral Immunity
24%
Immunoglobulin G
23%
COVID-19 Vaccination
22%
Syndrome
19%
Thrombocytopenia
19%
Woman
19%
Protein
18%
Immunoglobulin G Antibody
18%
Immunoassay
18%
Neutrophil
17%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Virus Nucleocapsid
16%
Virus Neutralization
16%
Messenger RNA
13%
COVID-19 Vaccine
13%
Fibrinogen
13%
Therapeutic Procedure
13%
Enzyme Linked Immunosorbent Assay
12%
Serum
12%
Drug Dose Regimen
12%
mRNA Vaccine
12%
Immunoglobulin A
11%
Virus
11%
Omicron Coronavirus Variant
11%
Biological Marker
11%
Blood
10%
Immune System
9%
Case Report
9%
Observational Study
9%
Coagulopathy
9%
Hospital
9%
Age
9%
Immunogenicity
9%
Cytokine Response
9%
Cells
9%
Transplantation
9%
Lung
9%
Septic Shock
9%
Nucleosome
9%
Systematic Review
9%
Laboratory Medicine
9%
Experience
9%
Immunoglobulin M Antibody
9%
Neonates
9%
Inpatient
9%
Cellular Immunity
9%
Plasma
8%
Wassermann Test
8%
In Vitro
8%
Immune Response
8%
Heparin
7%
Fibrinolysis
7%
Extracellular Trap
7%
Histone
7%
Platelet
7%
Blood Sampling
6%
Body Mass Index
6%
Molecular Diagnosis
6%
Serositis
6%
Thromboembolism
6%
Anticoagulation
6%
Analysis
5%
Reverse Transcription Polymerase Chain Reaction
5%
Symptom
5%
Protein Antibody
5%
Immunology and Microbiology
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Monospecific Antibody
72%
Neutralizing Antibody
60%
Antigen
56%
Sample
54%
COVID-19
45%
Vaccine Efficacy
42%
Immunoglobulin G Antibody
34%
Dose
22%
Binding Antibody
21%
Kinetics
20%
Immunoglobulin M Antibody
19%
Humoral Immunity
17%
Immunoassay
17%
Virus Nucleocapsid
16%
Dynamics
15%
Spike
15%
Antibody Response
15%
Viral Load
14%
Time
13%
NETosis
11%
ELISA
11%
Reverse Transcription Polymerase Chain Reaction
10%
Life
10%
Breakthrough Infection
9%
Immune System
9%
Omicron Coronavirus Variant
9%
Recognition
9%
Lung Transplantation
9%
Immunogenicity
9%
Respiratory Syncytial Virus
9%
Influenza
9%
Experience
9%
Inflammation
9%
Adoptive Immunity
9%
Immunoassay
8%
Neutrophil Granulocyte
7%
Drug Dose Regimen
7%
Pregnancy
6%
Immunoglobulin M
6%
Virus Neutralization
6%
Cross-Reactivity
5%
Titer
5%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
74%
Sample
40%
Antibody
39%
Hemostasis
29%
Kinetics
18%
Reverse Transcription Polymerase Chain Reaction
17%
Virus Load
14%
Thrombin
14%
Immunoglobulin G
13%
Fibrinolysis
13%
Molecular Array
9%
Laboratory Technique
9%
Nucleosome
9%
Neutralizing Antibody
9%
Recognition
9%
Immunoglobulin M
9%
Coronavirinae
9%
Blood Level
9%
Experience
9%
Quantitative Technique
9%
Heparin
9%
Time
7%
Histone
7%
Life
7%
Protein
6%
Virus Nucleocapsid
6%
Coagulation
6%
Dose
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Humoral Immunity
5%
Antibody Response
5%